USV slashes price of diabetes drug Jalra DP by 20 percent
In a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP, the commonly used antidiabetic drug.
JALRA DP is a combination of Vildaglitpin 100mg SR (sustained release) & Dapagliflozin 10mg which was earlier costing Rs 25 per tablet or Rs 250 per strip will now be available at price of Rs 19.9 per tablet.
Jalra-DP is indicated for the treatment of type 2 diabetes which works by improving both insulin resistance and beta cell function. Jalra-DP is usually prescribed when metformin alone or Sulfonylurea + metformin is ineffective in controlling Type-2 diabetes mellitus.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd